BW Businessworld
OPPI Elects S Sridhar As President
Sridhar is the Managing Director of Pfizer and is heading the company s commercial business in India
Photo Credit : Reuters
Industry body Organisation of Pharmaceutical Producers of India (OPPI) on Monday said it has elected S Sridhar as its next President for a period of two years, effective from February 15, 2021.
He takes over from former Managing Director of Boehringer Ingelheim India, Sharad Tyagi, OPPI said in a statement.
Sridhar is the Managing Director of Pfizer and is heading the company s commercial business in India, it added.
He has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group, OPPI said.
OPPI elects S Sridhar as new President
OPPI elects S Sridhar as new President
15 February 2021 | News Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently.
OPPI elects S Sridhar as new President
OPPI elects S Sridhar as new President
15 February 2021 | News Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently.
4-MIN READ
Covid-19: Indian health care comes of age
All stakeholders take note of marked improvements in Indian medicare system, call for innovation and continuity
FOLLOW US ON:
At the Ninth edition of the OPPI Annual Summit 2020 - Healthcare Accelerated,
Reimagining India s Healthcare in the next decade, country’s leading policy makers, members of the healthcare fraternity, heads of pharmaceutical companies, medical experts, NGOs and global think tanks converged to discuss diverse aspects of healthcare access, offering potential solutions.
Who’s who of the Health sector
Among the top-notch speakers who graced the occasion included D. V. Sadananda Gowda, Union Minister for Chemicals and Fertilisers and Mansukh Mandaviya, Minister of State for Shipping, Chemicals and Fertilizers. They were joined by S Aparna, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers.
OPPI brings high voltage discussion on healthcare transformation
OPPI brings high voltage discussion on healthcare transformation
17 December 2020 | News The two-day summit began with an address by Sharad Tyagi, President, OPPI on ‘Reimagining India’s Healthcare in the next decade’
Source credit: Shutterstock
DV Sadananda Gowda, Minister for Chemicals and Fertilisers, launched the 9th edition of Organisation of Pharmaceutical Producers of India (OPPI)’s Annual Summit - Healthcare Accelerated with the theme India’s Healthcare Transformational Journey, through the virtual platform on 17 December.
The two-day summit began with an address by Sharad Tyagi, President, OPPI on ‘Reimagining India’s Healthcare in the next decade’, followed by an address by KG Ananthakrishanan, Director General, OPPI on ‘Refreshing Research’.